Quantcast

Latest Epoxides Stories

2014-08-26 12:27:14

Sales of the LABA/LAMA Combination Drug Class are Expected to Grow Significantly Over the Next Six Months, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug. 26, 2014 /PRNewswire/ -- Decision Resources Group finds that two-thirds of surveyed pulmonologists indicate that Boehringer Ingelheim's Spiriva is the agent most likely to be replaced by GlaxoSmithKline/Theravance's first-in-class LABA/LAMA combination Anoro Ellipta. To date, surveyed physicians reported that, of...

2014-08-19 12:23:32

DALLAS, Aug. 19, 2014 /PRNewswire-iReach/ -- DeepResearchReports.com adds "2014 Deep Research Report on Global and China Epichlorohydrin Resin Industry" to its research database. (Photo - http://photos.prnewswire.com/prnh/20140819/137256) 2014 Deep Research Report on Global and China Epichlorohydrin Resin Industry" is a professional and in-depth research report on China and Global Epichlorohydrin Resin market. The report introduces Epichlorohydrin Resin basic information,...

2014-08-15 16:21:49

DUBLIN, Aug. 15, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global and Chinese Epichlorohydrin Resin Industry Report 2014 " report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The Global and Chinese Epichlorohydrin Resin Industry Report 2014 is a professional and in-depth study on the current state of the Global global epichlorohydrin industry with a focus on the Chinese situation. The report provides a basic overview of the...

2014-08-14 16:27:26

Committee Voted Based on Clinical Data from Eight Efficacy Trials RIDGEFIELD, Conn., Aug. 14, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted [10 yes, 3 no] that existing data supports approval of Boehringer Ingelheim's investigational tiotropium bromide inhalation spray for long-term, once-daily maintenance treatment of bronchospasm associated...

2014-08-04 08:27:13

Kyprolis Helped Patients Live 8.7 Months Longer Without Their Disease Worsening THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., Aug. 4, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its...

2014-06-24 16:21:49

DUBLIN, June 24, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/h7kcsw/global_and) has announced the addition of the "Global and Chinese Polyamine Polyamide - Epichlorohydrin Resin Industry Report 2014" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The Global and Chinese Polyamine Polyamide - Epichlorohydrin Resin Industry Report 2014 is a professional and in-depth study on the current state of the global Polyamine...

2014-06-23 23:08:57

Sterigenics International LLC, a global leader in outsourced contract sterilization services, today announced that it will invest more than $10 million to expand operations in Atlanta, Dallas and Belgium. Deerfield, IL (PRWEB) June 23, 2014 Sterigenics International LLC, a global leader in outsourced contract sterilization services, today announced that it will invest more than $10 million to expand operations in Atlanta, Dallas and Belgium. “Strong global customer demand is driving...

2014-04-24 12:28:48

Each of the Emerging LABA/LAMA Fixed-Dose Combinations Has Advantages Over Current Therapies on Efficacy Measures, According to Findings from Decision Resources Group BURLINGTON, Mass., April 24, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed U.S. and European pulmonologists agree that a therapy offering a greater reduction in exacerbations is among the areas of greatest opportunity for chronic obstructive pulmonary disease (COPD) treatments. The majority of surveyed U.S....

2014-04-22 16:23:30

DUBLIN, April 22, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/22h3kv/epichlorohydrin) has announced the addition of the "Epichlorohydrin (ECH): 2014 World Market Outlook and Forecast up to 2018" [http://www.researchandmarkets.com/research/22h3kv/epichlorohydrin ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Epichlorohydrin 2014 World Market Outlook and Forecast is an absolutely...

2014-04-10 08:23:50

DUBLIN, April 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/qv9mlq/analysis_and) has announced the addition of the "Analysis and Forecast of China Ethylene Oxide (EO) Industry" [http://www.researchandmarkets.com/research/qv9mlq/analysis_and ] report to their offering. At present, manufacturers can adjust the production proportion of ethylene oxide [http://www.researchandmarkets.com/research/qv9mlq/analysis_and ] (EO) and...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related